← 產業報告目錄
Nanomedicine Market Size, Share & Trends Analysis Report by Application (Therapeutics, In-Vitro Diagnostics, Drug Delivery, In-Vivo Imaging, And Implants), By Indication (Clinical Oncology, Infectious Diseases), By Molecule Type (Nanoparticles, Metal & Metal Oxide Nanoparticles, Liposomes, Polymers & Polymer-Drug Conjugates, Hydrogel Nanoparticles, Dendrimers, Inorganic Nanoparticles, Nanoshells, Nanotubes, And Nanodevices), Region And Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-26頁數 180報告編號 INSIGHTACE-781716e3ee
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
In 2024, the Nanomedicine Market worldwide was assessed at USD 213.4 Bn. Analysts project it will increase to USD 655.4 Bn by 2034, at a CAGR of 12.0% spanning 2025 to 2034.
Nanomedicine encompasses key industry insights & findings from the report:
Technological developments in areas like early illness diagnosis, chronic disease prevention, and preventative intervention are propelling the growth. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
Several factors contribute to this trajectory, including heightened need next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
From a regional perspective, mature markets in North America and Europe continue to hold considerable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and growing investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Nanomedicine Market Snapshot
Chapter 4. Global Nanomedicine Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of Metaverse Industry
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. COVID-19 Impact on Metaverse Industry
Chapter 5. Market Segmentation 1: By Application Estimates & Trend Analysis
5.1. By Application & Market Share, 2024-2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Application:
5.2.1. Therapeutics
5.2.2. in-vitro Diagnostics
5.2.3. Drug Delivery
5.2.4. In-vivo Imaging
5.2.5. Implants
Chapter 6. Market Segmentation 2: By Indication Estimates & Trend Analysis
6.1. By Indication & Market Share, 2024-2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Indication:
6.2.1. Clinical Oncology
6.2.2. Infectious diseases
6.2.3. Clinical Cardiology
6.2.4. Orthopedics
6.2.5. Others
Chapter 7. Market Segmentation 3: By Molecule Type Estimates & Trend Analysis
7.1. By Indication & Market Share, 2024-2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Molecule Type:
7.2.1. Nanoparticles
7.2.1.1. Metal & Metal Oxide Nanoparticles
7.2.1.2. Liposomes
7.2.1.3. Polymers & polymer-drug conjugates
7.2.1.4. Hydrogel Nanoparticles
7.2.1.5. Dendrimers
7.2.1.6. Inorganic Nanoparticles
7.2.2. Nanoshells
7.2.3. Nanotubes
7.2.4. Nanodevices
Chapter 8. Nanomedicine Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Nanomedicine Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
8.1.2. North America Nanomedicine Market revenue (US$ Million) estimates and forecasts By Indication, 2021-2034
8.1.3. North America Nanomedicine Market revenue (US$ Million) estimates and forecasts By Molecule Type, 2021-2034
8.1.4. North America Nanomedicine Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
8.1.4.1. U.S.
8.1.4.2. Canada
8.2. Europe
8.2.1. Europe Nanomedicine Market revenue (US$ Million) by By Application, 2021-2034
8.2.2. Europe Nanomedicine Market revenue (US$ Million) estimates and forecasts By Indication, 2021-2034
8.2.3. Europe Nanomedicine Market revenue (US$ Million) estimates and forecasts By Molecule Type, 2021-2034
8.2.4. Europe Nanomedicine Market revenue (US$ Million) by country, 2021-2034
8.2.4.1. Germany
8.2.4.2. Poland
8.2.4.3. France
8.2.4.4. Italy
8.2.4.5. Spain
8.2.4.6. UK
8.2.4.7. Rest of Europe
8.3. Asia Pacific
8.3.1. Asia Pacific Nanomedicine Market revenue (US$ Million) by By Application, 2021-2034
8.3.2. Asia Pacific Nanomedicine Market revenue (US$ Million) estimates and forecasts By Indication, 2021-2034
8.3.3. Asia Pacific Nanomedicine Market revenue (US$ Million) estimates and forecasts By Molecule Type, 2021-2034
8.3.4. Asia Pacific Nanomedicine Market revenue (US$ Million) by country, 2021-2034
8.3.4.1. China
8.3.4.2. India
8.3.4.3. Japan
8.3.4.4. Australia
8.3.4.5. Rest of Asia Pacific
8.4. Latin America
8.4.1. Latin America Nanomedicine Market revenue (US$ Million) by By Application, 2021-2034
8.4.2. Latin America Nanomedicine Market revenue (US$ Million) estimates and forecasts By Indication, 2021-2034
8.4.3. Latin America Nanomedicine Market revenue (US$ Million) estimates and forecasts By Molecule Type, 2021-2034
8.4.4. Latin America Nanomedicine Market revenue (US$ Million) by country, (US$ Million) 2021-2034
8.4.4.1. Brazil
8.4.4.2. Rest of Latin America
8.5. Middle East & Africa
8.5.1. Middle East & Africa Nanomedicine Market revenue (US$ Million) by By Application, (US$ Million)
8.5.2. Middle East & Africa Nanomedicine Market revenue (US$ Million) estimates and forecasts By Indication, 2021-2034
8.5.3. Middle East & Africa Nanomedicine Market revenue (US$ Million) estimates and forecasts By Molecule Type, 2021-2034
8.5.4. Middle East & Africa Nanomedicine Market revenue (US$ Million) by country, (US$ Million) 2021-2034
8.5.4.1. South Africa
8.5.4.2. GCC Countries
8.5.4.3. Rest of MEA
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Abbott Laboratories
9.2.2. CombiMatrix Corporation
9.2.3. Celgene Corporation
9.2.4. Nanospectra Biosciences, Inc.
9.2.5. GE Healthcare
9.2.6. Johnson & Johnson Services, Inc.
9.2.7. Mallinckrodt Pharmaceuticals
9.2.8. Merck & Co., Inc.
9.2.9. Pfizer, Inc.
9.2.10. Teva Pharmaceutical Industries Ltd.
9.2.11. Arrowhead Pharmaceuticals, Inc.
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們